Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03833830Completed
Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment
Neovascular Age-related Macular Degeneration
PrincipalinvestigatorStart date: 2019-01-07
NCT02307110Not ApplicableCompleted
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
Insulin-Dependent Diabetes Mellitus 1
PrincipalinvestigatorStart date: 2010-08-01
NCT02309281Phase 4Completed
Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab
Neovascular Age-related Macular Degeneration
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Vista Klinik Binningen

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03833830PrincipalInvestigator

Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment

Neovascular Age-related Macular Degeneration
Completed
NCT02307110Not ApplicablePrincipalInvestigator

Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy

Insulin-Dependent Diabetes Mellitus 1
Completed
NCT02309281Phase 4PrincipalInvestigator

Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab

Neovascular Age-related Macular Degeneration
Completed

All 3 trials loaded